Krystal Biotech Shares Outstanding 2017-2024 | KRYS

Krystal Biotech shares outstanding for the quarter ending June 30, 2024 were 0.030B, a 11.18% increase year-over-year.

  • Krystal Biotech 2023 shares outstanding were 0.028B, a 8.87% increase from 2022.
  • Krystal Biotech 2022 shares outstanding were 0.025B, a 14.84% increase from 2021.
  • Krystal Biotech 2021 shares outstanding were 0.022B, a 18.15% increase from 2020.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Krystal Biotech Shares Outstanding 2017-2024 | KRYS

  • Krystal Biotech 2023 shares outstanding were 0.028B, a 8.87% increase from 2022.
  • Krystal Biotech 2022 shares outstanding were 0.025B, a 14.84% increase from 2021.
  • Krystal Biotech 2021 shares outstanding were 0.022B, a 18.15% increase from 2020.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Related Stocks
Company NameMarket
Cap
Amgen (AMGN)$178.9B
Regeneron Pharmaceuticals (REGN)$125.5B
Vertex Pharmaceuticals (VRTX)$122.4B
Gilead Sciences (GILD)$104.4B
Bristol Myers Squibb (BMY)$100.8B
CSL (CSLLY)$96.8B
GSK (GSK)$87.9B
Alnylam Pharmaceuticals (ALNY)$35.1B
Argenex SE (ARGX)$31.6B
Biogen (BIIB)$28.8B
BioNTech SE (BNTX)$27.5B
Moderna (MRNA)$26.9B
Illumina (ILMN)$20.9B
BeiGene (BGNE)$19.2B
Genmab (GMAB)$17.3B
BioMarin Pharmaceutical (BMRN)$13.5B
Vaxcyte (PCVX)$13B
Exact Sciences (EXAS)$12.8B
Incyte (INCY)$12.6B
Insmed (INSM)$12.5B
Bio-Techne Corp (TECH)$12.1B
Sarepta Therapeutics (SRPT)$11.9B
QIAGEN (QGEN)$10.4B
Bio-Rad Laboratories (BIO.B)$9.1B
Legend Biotech (LEGN)$9.1B
Roivant Sciences (ROIV)$8.9B
Ascendis Pharma (ASND)$8.7B
Repligen (RGEN)$8B
Halozyme Therapeutics (HALO)$7.9B
Intra-Cellular Therapies (ITCI)$7.9B